These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 31626797

  • 1. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A, Prusakiewicz JJ, Oswald J, Spencer E, Lou Z, Cohen ML, Rashidzadeh H, Josiah S.
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [Abstract] [Full Text] [Related]

  • 2. Effects of TAK-639, a novel topical C-type natriuretic peptide analog, on intraocular pressure and aqueous humor dynamics in mice.
    Millar JC, Savinainen A, Josiah S, Pang IH.
    Exp Eye Res; 2019 Nov; 188():107763. PubMed ID: 31421135
    [Abstract] [Full Text] [Related]

  • 3. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G, Carreiro S, Anderson S, Gukasyan H, Sartnurak S, Younis H, Gale D, Xiang C, Wells P, Dinh D, Almaden C, Fortner J, Toris C, Niesman M, Lafontaine J, Krauss A.
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF, Krupin T, Tang LQ, Hong PH, Ruderman JM.
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [Abstract] [Full Text] [Related]

  • 8. Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure-lowering activity in rodent eyes.
    Stankowska DL, Millar JC, Kodati B, Behera S, Chaphalkar RM, Nguyen T, Nguyen KT, Krishnamoorthy RR, Ellis DZ, Acharya S.
    Mol Vis; 2021 Jan; 27():37-49. PubMed ID: 33633438
    [Abstract] [Full Text] [Related]

  • 9. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
    Krauss AH, Impagnatiello F, Toris CB, Gale DC, Prasanna G, Borghi V, Chiroli V, Chong WK, Carreiro ST, Ongini E.
    Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
    [Abstract] [Full Text] [Related]

  • 10. Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.
    Faulkner R, Sharif NA, Orr S, Sall K, Dubiner H, Whitson JT, Moster M, Craven ER, Curtis M, Pailliotet C, Martens K, Dahlin D.
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):147-56. PubMed ID: 20307216
    [Abstract] [Full Text] [Related]

  • 11. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.
    Wang RF, Lee PY, Mittag TW, Podos SM, Serle JB, Becker B.
    Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682
    [Abstract] [Full Text] [Related]

  • 12. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
    Wang RF, Gagliuso DJ, Podos SM.
    J Glaucoma; 2008 Sep; 17(1):73-8. PubMed ID: 18303390
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent.
    Kirihara T, Taniguchi T, Yamamura K, Iwamura R, Yoneda K, Odani-Kawabata N, Shimazaki A, Matsugi T, Shams N, Zhang JZ.
    Invest Ophthalmol Vis Sci; 2018 Jan 01; 59(1):145-153. PubMed ID: 29332128
    [Abstract] [Full Text] [Related]

  • 15. Mechanism - based translational pharmacokinetic - pharmacodynamic model to predict intraocular pressure lowering effect of drugs in patients with glaucoma or ocular hypertension.
    Durairaj C, Shen J, Cherukury M.
    Pharm Res; 2014 Aug 01; 31(8):2095-106. PubMed ID: 24549827
    [Abstract] [Full Text] [Related]

  • 16. NCX 1741, a Novel Nitric Oxide-Donating Phosphodiesterase-5 Inhibitor, Exerts Rapid and Long-Lasting Intraocular Pressure-Lowering in Cynomolgus Monkeys.
    Bastia E, Toris C, Bukowski JM, Brambilla S, Galli C, Almirante N, Bergamini MVW, Lucarini L, Navratil T, Impagnatiello F.
    J Ocul Pharmacol Ther; 2021 May 01; 37(4):215-222. PubMed ID: 33595367
    [Abstract] [Full Text] [Related]

  • 17. NCX 667, a Novel Nitric Oxide Donor, Lowers Intraocular Pressure in Rabbits, Dogs, and Non-Human Primates and Enhances TGFβ2-Induced Outflow in HTM/HSC Constructs.
    Bastia E, Toris CB, Brambilla S, Galli C, Almirante N, Bergamini MVW, Masini E, Sgambellone S, Unser AM, Ahmed F, Torrejon KY, Navratil T, Impagnatiello F.
    Invest Ophthalmol Vis Sci; 2021 Mar 01; 62(3):17. PubMed ID: 33704360
    [Abstract] [Full Text] [Related]

  • 18. Effect of 5-methylurapidil, an alpha 1a-adrenergic antagonist and 5-hydroxytryptamine1a agonist, on aqueous humor dynamics in monkeys and rabbits.
    Wang RF, Lee PY, Mittag TW, Podos SM, Serle JB.
    Curr Eye Res; 1997 Aug 01; 16(8):769-75. PubMed ID: 9255505
    [Abstract] [Full Text] [Related]

  • 19. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF, Gautheron P, Mallorga P, Nolan TE, Graham SL, Schwam H, Shepard KL, Smith RL.
    Br J Pharmacol; 1990 Jan 01; 99(1):59-64. PubMed ID: 2110013
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles.
    Halder A, Khopade AJ.
    Curr Eye Res; 2021 Jul 01; 46(7):1031-1037. PubMed ID: 33719796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.